Laurie Proulx has relied on medication to manage the pain of a chronic illness she’s been living with for decades.

Using the card, Gruber usually met that maximum by February, leaving his health insurance to fully cover his in-network ...

While some states ban insurers from using copay accumulator programs, oversight has stalled at the federal level.

Cellares operates its first commercial-scale Smart Factory in New Jersey, with additional facilities under construction in ...

Combined company plans to advance nebokitug, a first-in-class anti-CCL24 antibody, through a precision medicine Phase 2 trial in rheumatoid ...

In a position statement published earlier this year, the American College of Clinical Pharmacy called for the total ...

AbbVie gains attention as healthcare rotation highlights Skyrizi, Rinvoq, immunology growth, and portfolio strength beyond ...

Yet, it may really surprise you that this material, once discarded without a second thought, is now being recognised as a ...

AbbVie’s Tepkinly approval strengthens its oncology outlook, while cash-flow estimates and elevated earnings measures create ...

Combined company plans to advance nebokitug, a first-in-class anti-CCL24 antibody, through a precision medicine Phase 2 trial in rheumatoid arthritis (RA) by leveraging Scipher's AI Network Medicine ...

The opening ceremony centred on the importance of movement for people living with rheumatic and musculoskeletal diseases (RMD ...